← FDA Drug Approvals (Drugs@FDA)

CLADRIBINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2011-10-06

Drug application

FDA Application #
ANDA200510
Application type
Abbreviated New Drug Application (Generic)
Brand name
CLADRIBINE
Generic name
Cladribine
Active ingredients
CLADRIBINE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
PHARMOBEDIENT
First approval
2011-10-06

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown